2026 ICD-10-CM Diagnosis Code T39.312SPoisoning by propionic acid derivatives, intentional self-harm, sequela

ICD-10-CM Codes›S00–T88›T36-T50›T39

ICD-10-CM T39.312S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T39.312S is a billable ICD-10-CM diagnosis code for poisoning by propionic acid derivatives, intentional self-harm, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders; sequela; and Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T39.312S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by propionic acid derivatives, intentional self-harm, sequela
Short Description
Poisoning by propionic acid derivatives, self-harm, sequela
Parent Code
T39.312
Poisoning by propionic acid derivatives, intentional self-harm

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT39Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
This CodeT39.312SPoisoning by propionic acid derivatives, intentional self-harm, sequela

Present on Admission (POA)Billing

T39.312S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Fenoprofen overdose
  • Fenoprofen poisoning
  • Flurbiprofen overdose
  • Flurbiprofen poisoning
  • Ibuprofen overdose
  • Ibuprofen poisoning
  • Intentional fenoprofen overdose
  • Intentional fenoprofen poisoning
  • Intentional flurbiprofen overdose
  • Intentional flurbiprofen poisoning
  • Intentional ibuprofen overdose
  • Intentional ibuprofen poisoning
  • Intentional ketoprofen overdose
  • Intentional ketoprofen poisoning
  • Intentional naproxen overdose
  • Intentional naproxen poisoning
  • Intentional tiaprofenic acid overdose
  • Intentional tiaprofenic acid poisoning
  • Ketoprofen overdose
  • Ketoprofen poisoning
  • Naproxen overdose
  • Naproxen poisoning
  • Tiaprofenic acid overdose
  • Tiaprofenic acid poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics (T39). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD034
Mental and substance use disorders; sequela
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Fenoprofen

    a propionic acid derivative that is used as a non-steroidal anti-inflammatory agent.

  • Flurbiprofen

    an anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. it has been shown to reduce bone resorption in periodontal disease by inhibiting carbonic anhydrase.

  • Ibuprofen

    a non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties

  • Ketoprofen

    an ibuprofen-type anti-inflammatory analgesic and antipyretic. it is used in the treatment of rheumatoid arthritis and osteoarthritis.

  • Carboxylesterase

    carboxylesterase is a serine-dependent esterase with wide substrate specificity. the enzyme is involved in the detoxification of xenobiotics and the activation of ester and of amide prodrugs.

  • Naproxen

    an anti-inflammatory agent with analgesic and antipyretic properties. both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

  • Oxaprozin

    an oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of osteoarthritis; rheumatoid arthritis; and arthritis, juvenile.

  • Suprofen

    an ibuprofen-type anti-inflammatory analgesic and antipyretic. it inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect		Under­dosing
CarprofenT39.311T39.312T39.313T39.314T39.315T39.316
EsflurbiprofenT39.311T39.312T39.313T39.314T39.315T39.316
FenoprofenT39.311T39.312T39.313T39.314T39.315T39.316
FlurbiprofenT39.311T39.312T39.313T39.314T39.315T39.316
IbufenacT39.311T39.312T39.313T39.314T39.315T39.316
IbuprofenT39.311T39.312T39.313T39.314T39.315T39.316
IbuproxamT39.311T39.312T39.313T39.314T39.315T39.316
KetoprofenT39.311T39.312T39.313T39.314T39.315T39.316
NaproxenT39.311T39.312T39.313T39.314T39.315T39.316
OxaprozinT39.311T39.312T39.313T39.314T39.315T39.316
SuprofenT39.311T39.312T39.313T39.314T39.315T39.316
Tiaprofenic acidT39.311T39.312T39.313T39.314T39.315T39.316

Patient EducationClinical

Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T39.312S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E959 Late eff of self-injury
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T39.312SOverview

Is T39.312S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by propionic acid derivatives, intentional self-harm, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T39.312S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by propionic acid derivatives, intentional self-harm itself has resolved, not the original event.

What MS-DRG does T39.312S group to?

When poisoning by propionic acid derivatives, intentional self-harm, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T39.312S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by propionic acid derivatives, intentional self-harm, sequela on inpatient claims.

What is the ICD-9 equivalent of T39.312S?

Under the General Equivalence Mappings, poisoning by propionic acid derivatives, intentional self-harm, sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E959 (late eff of self-injury). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.